arrow
K

Ki-Dong Yoo

st vincent's hospital
H指数:32
被引数:3,029

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Edoxaban Antithrombotic Therapy in Diabetic Patients with Atrial Fibrillation and Stable Coronary Artery Disease: The EPIC-CAD Trial

依度沙班抗血栓治疗在合并心房颤动和稳定型冠状动脉疾病的糖尿病患者中的应用:EPIC-CAD试验

2026-09-030
OAAI
Sex-Based Differences in Clinical Outcomes With Edoxaban Therapy A Prespecified Analysis of the EPIC-CAD Trial

基于性别差异的临床结局与依度沙班治疗:EPIC-CAD试验的预设分析

2026-05-011
OAAI
The efficacy and safety of prasugrel in acute coronary syndrome: a propensity-matched Korean cohort study focused on age and weight of patients

普拉格雷在急性冠状动脉综合征中的有效性和安全性:一项关注患者年龄和体重的倾向性匹配韩国队列研究

2025-11-260
PRE
Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study

Evolocumab在韩国动脉粥样硬化性心血管疾病或家族性高胆固醇血症患者中的真实世界安全性与有效性:一项上市后监测研究

2025-10-080
OA
Long-Term Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior PCI

心房颤动且先前接受过PCI的患者长期抗栓治疗

JACC
IF0
2025-08-270
PRE
Clinical Outcomes of Transradial Versus Transfemoral Approach in Rotational Atherectomy: Results from the Rotational Atherectomy in Calcified Lesions in Korea (ROCK) Registry

经桡动脉与经股动脉途径在旋磨术中的临床结局比较:韩国钙化病变旋磨术(ROCK)注册研究的结果

2025-04-290
OA
BMI and Deescalation From Ticagrelor to Clopidogrel in Patients With Acute Myocardial Infarction A Post Hoc Analysis of the TALOS-AMI Trial

体重指数及从替格瑞洛转换为氯吡格雷在急性心肌梗死患者中的降级治疗:TALOS-AMI试验的事后分析

2025-02-271
OA
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
2024-12-054
PRE